ArticleTurkish journal of medical sciences2026
Urinary DKK3 as a predictor of CKD stages in reflux nephropathy in children.
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: Reflux nephropathy is an important cause of chronic kidney disease (CKD) in children. The search for new biomarkers continues, as early intervention is important to slow the progression of CKD. Urinary Dickkopf-3 (uDKK3), a potential marker of tubulointerstitial fibrosis, has been studied in adults but not extensively in children with CKD. This study was conducted to determine the role of uDKK3 levels in predicting the CKD stage in children with reflux nephropathy. Materials and methods: This cross-sectional study included 113 children with CKD stages 1-4 with reflux nephropathy and 28 healthy controls. uDKK3 concentrations were measured using enzyme-linked immunosorbent assay. The association between uDKK3, the estimated glomerular filtration rate (eGFR), and albuminuria was investigated. Receiver operating characteristic (ROC) curves were used to assess diagnostic performance. Results: uDKK3 levels were significantly higher in CKD stages 3 and 4 compared to stages 1 and 2 and the control group. A strong negative correlation was observed between uDKK3 and the eGFR, while a positive correlation was noted with albuminuria. ROC analysis revealed an area under the curve (AUC) of 0.77 for the uDKK3 to urinary Cr (uCr) ratio (uDKK3/uCr), with a sensitivity of 71.1% and a specificity of 71.4% at a cutoff value of 1675.48 pg/mg. Conclusion: The correlation between the uDKK3/uCr and CKD severity suggests that uDKK3 may serve as a potential noninvasive biomarker for assessing disease severity. However, its utility for identifying early-stage CKD could not be clearly demonstrated in this cohort. uDKK3 appears to be particularly associated with advanced CKD stages, and further large-scale prospective studies are needed to clarify its clinical applicability and prognostic value in pediatric CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.